Intuitive Surgical, Inc. (0R29.L)
USD 532.14
(2.67%)
USD 532.14
(2.67%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.12 Billion USD | 14.49% |
| 2022 | 6.22 Billion USD | 8.97% |
| 2021 | 5.71 Billion USD | 31.01% |
| 2020 | 4.35 Billion USD | -2.68% |
| 2019 | 4.47 Billion USD | 20.25% |
| 2018 | 3.72 Billion USD | 19.03% |
| 2017 | 3.12 Billion USD | 15.7% |
| 2016 | 2.7 Billion USD | 13.42% |
| 2015 | 2.38 Billion USD | 11.85% |
| 2014 | 2.13 Billion USD | -5.89% |
| 2013 | 2.26 Billion USD | 3.96% |
| 2012 | 2.17 Billion USD | 23.99% |
| 2011 | 1.75 Billion USD | 24.37% |
| 2010 | 1.41 Billion USD | 34.29% |
| 2009 | 1.05 Billion USD | 20.26% |
| 2008 | 874.91 Million USD | 45.62% |
| 2007 | 600.82 Million USD | 61.22% |
| 2006 | 372.68 Million USD | 63.93% |
| 2005 | 227.33 Million USD | 63.78% |
| 2004 | 138.8 Million USD | 51.41% |
| 2003 | 91.67 Million USD | 27.29% |
| 2002 | 72.02 Million USD | 39.38% |
| 2001 | 51.67 Million USD | 94.08% |
| 2000 | 26.62 Million USD | 161.22% |
| 1999 | 10.19 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 2.03 Billion USD | 1.4% |
| 2024 Q1 | 1.89 Billion USD | -1.96% |
| 2024 Q2 | 2 Billion USD | 6.31% |
| 2023 Q3 | 1.74 Billion USD | -0.69% |
| 2023 Q2 | 1.75 Billion USD | 3.52% |
| 2023 Q1 | 1.69 Billion USD | 2.49% |
| 2023 FY | 7.12 Billion USD | 14.49% |
| 2023 Q4 | 1.92 Billion USD | 10.59% |
| 2022 Q3 | 1.55 Billion USD | 2.32% |
| 2022 Q1 | 1.48 Billion USD | -4.06% |
| 2022 FY | 6.22 Billion USD | 8.97% |
| 2022 Q4 | 1.65 Billion USD | 6.27% |
| 2022 Q2 | 1.52 Billion USD | 2.31% |
| 2021 FY | 5.71 Billion USD | 31.01% |
| 2021 Q2 | 1.46 Billion USD | 13.3% |
| 2021 Q1 | 1.29 Billion USD | -2.78% |
| 2021 Q4 | 1.55 Billion USD | 10.5% |
| 2021 Q3 | 1.4 Billion USD | -4.15% |
| 2020 Q3 | 1.07 Billion USD | 26.48% |
| 2020 FY | 4.35 Billion USD | -2.68% |
| 2020 Q1 | 1.09 Billion USD | -13.95% |
| 2020 Q2 | 852.1 Million USD | -22.5% |
| 2020 Q4 | 1.32 Billion USD | 23.33% |
| 2019 FY | 4.47 Billion USD | 20.25% |
| 2019 Q4 | 1.27 Billion USD | 13.25% |
| 2019 Q3 | 1.12 Billion USD | 2.67% |
| 2019 Q2 | 1.09 Billion USD | 12.86% |
| 2019 Q1 | 973.7 Million USD | -6.96% |
| 2018 Q2 | 909.3 Million USD | 7.29% |
| 2018 Q4 | 1.04 Billion USD | 13.64% |
| 2018 FY | 3.72 Billion USD | 19.03% |
| 2018 Q1 | 847.5 Million USD | -5.03% |
| 2018 Q3 | 920.9 Million USD | 1.28% |
| 2017 Q2 | 756.2 Million USD | 12.16% |
| 2017 Q1 | 674.2 Million USD | -10.93% |
| 2017 FY | 3.12 Billion USD | 15.7% |
| 2017 Q4 | 892.4 Million USD | 10.71% |
| 2017 Q3 | 806.1 Million USD | 6.6% |
| 2016 Q4 | 756.9 Million USD | 10.84% |
| 2016 Q2 | 670.1 Million USD | 12.72% |
| 2016 Q3 | 682.9 Million USD | 1.91% |
| 2016 FY | 2.7 Billion USD | 13.42% |
| 2016 Q1 | 594.5 Million USD | -12.12% |
| 2015 Q1 | 532.1 Million USD | -12.01% |
| 2015 Q2 | 586.1 Million USD | 10.15% |
| 2015 Q3 | 589.7 Million USD | 0.61% |
| 2015 FY | 2.38 Billion USD | 11.85% |
| 2015 Q4 | 676.5 Million USD | 14.72% |
| 2014 Q4 | 604.7 Million USD | 9.93% |
| 2014 Q1 | 464.7 Million USD | -19.35% |
| 2014 FY | 2.13 Billion USD | -5.89% |
| 2014 Q2 | 512.2 Million USD | 10.22% |
| 2014 Q3 | 550.1 Million USD | 7.4% |
| 2013 Q4 | 576.2 Million USD | 15.47% |
| 2013 Q2 | 578.5 Million USD | -5.38% |
| 2013 Q1 | 611.4 Million USD | 0.34% |
| 2013 FY | 2.26 Billion USD | 3.96% |
| 2013 Q3 | 499 Million USD | -13.74% |
| 2012 Q1 | 495.2 Million USD | -0.32% |
| 2012 FY | 2.17 Billion USD | 23.99% |
| 2012 Q4 | 609.3 Million USD | 13.29% |
| 2012 Q3 | 537.8 Million USD | 0.24% |
| 2012 Q2 | 536.5 Million USD | 8.34% |
| 2011 Q4 | 496.8 Million USD | 11.22% |
| 2011 Q3 | 446.7 Million USD | 4.93% |
| 2011 FY | 1.75 Billion USD | 24.37% |
| 2011 Q2 | 425.7 Million USD | 9.69% |
| 2011 Q1 | 388.1 Million USD | -0.31% |
| 2010 Q2 | 350.7 Million USD | 6.73% |
| 2010 Q4 | 389.3 Million USD | 13.04% |
| 2010 Q3 | 344.4 Million USD | -1.8% |
| 2010 Q1 | 328.6 Million USD | 1.72% |
| 2010 FY | 1.41 Billion USD | 34.29% |
| 2009 Q1 | 188.37 Million USD | -18.65% |
| 2009 FY | 1.05 Billion USD | 20.26% |
| 2009 Q4 | 323.03 Million USD | 15.32% |
| 2009 Q3 | 280.13 Million USD | 7.49% |
| 2009 Q2 | 260.62 Million USD | 38.36% |
| 2008 Q4 | 231.54 Million USD | -1.88% |
| 2008 FY | 874.91 Million USD | 45.62% |
| 2008 Q3 | 235.99 Million USD | 7.67% |
| 2008 Q2 | 219.18 Million USD | 16.47% |
| 2008 Q1 | 188.19 Million USD | -0.66% |
| 2007 Q3 | 156.9 Million USD | 11.88% |
| 2007 Q2 | 140.24 Million USD | 22.78% |
| 2007 Q1 | 114.22 Million USD | 1.48% |
| 2007 FY | 600.82 Million USD | 61.22% |
| 2007 Q4 | 189.44 Million USD | 20.74% |
| 2006 Q3 | 95.83 Million USD | 10.12% |
| 2006 FY | 372.68 Million USD | 63.93% |
| 2006 Q2 | 87.02 Million USD | 12.64% |
| 2006 Q1 | 77.25 Million USD | 7.16% |
| 2006 Q4 | 112.56 Million USD | 17.46% |
| 2005 Q2 | 52.75 Million USD | 26.77% |
| 2005 Q3 | 60.87 Million USD | 15.39% |
| 2005 Q4 | 72.09 Million USD | 18.43% |
| 2005 Q1 | 41.61 Million USD | -7.92% |
| 2005 FY | 227.33 Million USD | 63.78% |
| 2004 Q4 | 45.19 Million USD | 27.33% |
| 2004 Q1 | 27.05 Million USD | -1.94% |
| 2004 Q2 | 31.05 Million USD | 14.78% |
| 2004 Q3 | 35.49 Million USD | 14.28% |
| 2004 FY | 138.8 Million USD | 51.41% |
| 2003 Q2 | 21.45 Million USD | 11.53% |
| 2003 FY | 91.67 Million USD | 27.29% |
| 2003 Q1 | 19.23 Million USD | -9.03% |
| 2003 Q4 | 27.59 Million USD | 17.96% |
| 2003 Q3 | 23.39 Million USD | 9.04% |
| 2002 Q3 | 17.08 Million USD | -11.89% |
| 2002 Q4 | 21.14 Million USD | 23.79% |
| 2002 Q2 | 19.38 Million USD | 34.55% |
| 2002 Q1 | 14.4 Million USD | -10.02% |
| 2002 FY | 72.02 Million USD | 39.38% |
| 2001 Q4 | 16.01 Million USD | 47.44% |
| 2001 Q2 | 12.72 Million USD | 5.31% |
| 2001 Q1 | 12.07 Million USD | 12.82% |
| 2001 FY | 51.67 Million USD | 94.08% |
| 2001 Q3 | 10.86 Million USD | -14.61% |
| 2000 Q4 | 10.7 Million USD | 36.23% |
| 2000 Q3 | 7.85 Million USD | 53.29% |
| 2000 FY | 26.62 Million USD | 161.22% |
| 2000 Q2 | 5.12 Million USD | 74.8% |
| 2000 Q1 | 2.93 Million USD | 0.0% |
| 1999 FY | 10.19 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -1899.472% |
| Accuray Incorporated | 446.55 Million USD | -1495.361% |
| Align Technology, Inc. | 3.86 Billion USD | -84.454% |
| Elevance Health Inc. | 171.34 Billion USD | 95.842% |
| AxoGen, Inc. | 159.01 Million USD | -4380.228% |
| Boston Scientific Corporation | 14.24 Billion USD | 49.971% |
| CVS Health Corporation | 357.77 Billion USD | 98.009% |
| Cardinal Health, Inc. | 226.82 Billion USD | 96.859% |
| Centene Corporation | 141.26 Billion USD | 94.957% |
| DaVita Inc. | 12.14 Billion USD | 41.318% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 89.034% |
| Hologic, Inc. | 4.03 Billion USD | -76.764% |
| Humana Inc. | 106.37 Billion USD | 93.303% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -94.597% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 41.421% |
| Masimo Corporation | 2.04 Billion USD | -247.839% |
| McKesson Corporation | 308.95 Billion USD | 97.694% |
| Patterson Companies, Inc. | 6.56 Billion USD | -8.462% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 22.999% |
| ResMed Inc. | 4.68 Billion USD | -52.052% |
| Henry Schein, Inc. | 12.33 Billion USD | 42.264% |
| Teladoc Health, Inc. | 2.6 Billion USD | -173.75% |
| Universal Health Services, Inc. | 14.28 Billion USD | 50.118% |
| Veeva Systems Inc. | 2.36 Billion USD | -201.4% |
| Baxter International Inc. | 14.81 Billion USD | 51.906% |
| Becton, Dickinson and Company | 19.37 Billion USD | 63.225% |
| Danaher Corporation | 23.89 Billion USD | 70.18% |
| Stryker Corporation | 20.49 Billion USD | 65.245% |
| Medtronic plc | 32.36 Billion USD | 77.988% |